O'Brien Wealth Partners LLC Regeneron Pharmaceuticals, Inc. Transaction History

O'Brien Wealth Partners LLC

  • $484 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 17, 2019
SELL
$335.82 - $403.04 $13,432 - $16,121
-40 Closed
0 $0
Q3 2018

Oct 09, 2018
BUY
$351.14 - $408.51 $14,045 - $16,340
40 New
40 $16,000
Q2 2018

Jul 11, 2018
SELL
$284.6 - $344.99 $11,384 - $13,799
-40 Closed
0 $0
Q1 2018

Apr 11, 2018
BUY
$315.82 - $393.78 $12,632 - $15,751
40 New
40 $14,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track O'Brien Wealth Partners LLC Portfolio

Follow O'Brien Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Brien Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Brien Wealth Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email